- Home
- JMG vs THAR Comparison
JMG vs THAR Comparison
Compare JMG & THAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$2.25
Company Overview
Basic Information| Metric | JMG | THAR |
|---|---|---|
| Founded | 2016 | 2017 |
| Country | Hong Kong | United States |
| Employees | N/A | 3 |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 97.8M | 82.7M |
| IPO Year | 2025 | 2022 |
Fundamental Metrics
Financial Performance| Metric | JMG | THAR |
|---|---|---|
| Price | $6.10 | $2.25 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 2.1M | 277.1K |
| Earning Date | 01-01-0001 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.12 | N/A |
| Revenue | ★ $30,782,659.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $52.07 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.23 | $0.95 |
| 52 Week High | $9.60 | $9.08 |
Technical Indicators
Market Signals| Indicator | JMG | THAR |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 37.59 |
| Support Level | N/A | $2.32 |
| Resistance Level | N/A | $2.75 |
| Average True Range (ATR) | 0.00 | 0.17 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 0.00 | 5.66 |
Price Performance
Historical Comparison JMG
THAR
About THAR Tharimmune Inc.
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.